| |
| | A New Type of Antimetastatic Peptide Derived from Fibronectin -- Kato et al. 8 (7): 2455 -- Clinical Cancer Research |
 | | Matsumoto Y., Saiki I., Makabe T., Yoneda J., Murata J., Kimizuka I., Ishizaki Y., Kato I., Azuma I. Inhibitory effect of antimetastatic fusion polypeptide of human fibronectin on tumor cell adhesion to extracellular matrices. |
 | | Saiki I., Murata J., Makabe T., Matsumoto Y., Ohdate Y., Kawase Y., Taguchi Y., Shimojo T., Kimizuka F., Kato I., Azuma I. Inhibition of lung metastasis by synthetic and recombinant fragments of human fibronectin with functional domains. |
 | | Saiki I., Matsumoto Y., Murata J., Makabe T., Yoneda J., Okuyama H., Kimizuka F., Ishizaka Y., Kato I., Azuma I. Recombinant fusion polypeptide with cell- and heparin-binding domains of fibronectin inhibits liver metastais of L5178Y-ML25 lymphoma cells. |
| clincancerres.aacrjournals.org /cgi/content/full/8/7/2455 (4602 words) |
|